Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity
- PMID: 39639682
- PMCID: PMC11984674
- DOI: 10.1111/acel.14429
Phenotypic upregulation of hexocylceramides and ether-linked phosphocholines as markers of human extreme longevity
Abstract
Centenarians and their relatives possess a notable survival advantage, with higher longevity and reduced susceptibility to major age-related diseases. To date, characteristic omics profiles of centenarians have been described, demonstrating that these individuals with exceptional longevity regulate their metabolism to adapt and incorporate more resilient biomolecules into their cells. Among these adaptations, the lipidomic profile stands out. However, it has not yet been determined whether this lipidomic profile is specific to centenarians or is the consequence of extreme longevity genetics and is also present in centenarians' offspring. This distinction is crucial for defining potential therapeutic targets that could help delay the aging process and associated pathologies. We applied mass-spectrometry-based techniques to quantify 569 lipid species in plasma samples from 39 centenarians, 63 centenarians' offspring, and 69 noncentenarians' offspring without familial connections. Based on this profile, we calculated different indexes to characterize the functional and structural properties of plasma lipidome. Our findings demonstrate that extreme longevity genetics (centenarians and centenarians' offspring) determines a specific lipidomic signature characterized by (i) an enrichment of hexosylceramides, (ii) a decrease of specific species of ceramides and sulfatides, (iii) a global increase of ether-PC and ether-LPC, and (iv) changes in the fluidity and diversity of specific lipid classes. We point out the conversion of ceramides to hexosylceramides and the maintenance of the levels of the ether-linked PC as a phenotypic trait to guarantee extreme longevity. We propose that this molecular signature is the result of an intrinsic adaptive program that preserves protective mechanisms and cellular identity.
Keywords: centenarians; cententarians' offspring; ether lipids; extreme longevity; hexocylceramides; lipidomics.
© 2024 The Author(s). Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that this research was conducted in the absence of any commercial or financial relationship that could be considered as a potential conflict of interest.
Figures
References
-
- Adams, E. R. , Nolan, V. G. , Andersen, S. L. , Perls, T. T. , & Terry, D. F. (2008). Centenarian offspring: Start healthier and stay healthier. Journal of the American Geriatrics Society, 56, 2089–2092. https://pubmed.ncbi.nlm.nih.gov/18811609/Accessed February 9, 2024 - PMC - PubMed
-
- Alshehry, Z. H. , Barlow, C. K. , Weir, J. M. , Zhou, Y. , Mcconville, M. J. , & Meikle, P. J. (2015). An efficient single phase method for the extraction of plasma lipids. Metabolites, 5, 389–403. www.mdpi.com/journal/metabolites/Article. Accessed March 30, 2023 - PMC - PubMed
-
- Ash, A. S. , Kroll‐Desrosiers, A. R. , Hoaglin, D. C. , Christensen, K. , Fang, H. , & Perls, T. T. (2015). Are members of long‐lived families healthier than their equally long‐lived peers? Evidence from the long life family study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 70, 971–976. - PMC - PubMed
-
- Atzmon, G. , Schechter, C. , Greiner, W. , Davidson, D. , Rennert, G. , & Barzilai, N. (2004). Clinical phenotype of families with longevity. Journal of the American Geriatrics Society, 52, 274–277. https://pubmed.ncbi.nlm.nih.gov/14728640/. Accessed February 9, 2024 - PubMed
MeSH terms
Substances
Grants and funding
- PID2020-113839RB-I00/Ministerio de Ciencia y Tecnología
- PID2023-152233OB-I00/Ministerio de Ciencia y Tecnología
- PP10605-PIRS2021/Diputació de Lleida
- PP10845-PIRS2023/Diputació de Lleida
- AC20/00026/Instituto de Salud Carlos III
- CB16/10/00435 (CIBERFES)/Instituto de Salud Carlos III
- PI24/01431/Instituto de Salud Carlos III
- CIAICO/2022/190/Conselleria d'Educació, Investigació, Cultura i Esport
- 2021SGR00990/Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- 696295/Horizon 2020 Framework Programme
- 825546/Horizon 2020 Framework Programme
LinkOut - more resources
Full Text Sources
